The Council added it had received proposals from 19 cities seeking to host the European Medicines Agency (EMA) and eight candidate cities for the European Banking Authority (EBA).
Monday was the last day to apply, and the list was published on Tuesday by the Council of the European Union, where representatives of member states meet.
The European Commission will assess the entries based on the quality of office space, job opportunities for spouses and transport links.
A total of 21 states today put in a bid to host one or both of the bodies - meaning almost every European country wants to get involved.
Cities interested in the banking authority include Brussels, Dublin, Frankfurt, Paris, Prague, Luxembourg, Vienna and Warsaw.
Each country could bid to host one or both agencies, but was only allowed one bid per agency.
Amsterdam, Athens, Barcelona, Bonn, Bratislava, Brussels, Bucharest, Copenhagen, Dublin, Helsinki, Lille (France), Milan, Porto (Portugal), Sofia (Bulgaria), Stockholm, Malta, Vienna, Warsaw and Zagreb (Croatia) are vying for the medicines agency.
Apple Blocks VPN Apps From China App Store
Apple's China revenues have stalled, falling for a fifth straight quarter in January-March, when sales grew in every other region. The Chinese crackdown on VPNs is not particularly shocking, given the country's well-known isolation from the broader internet.
The EMA employs almost 900 staff and acts as a one-stop-shop for approving and monitoring the safety of drugs across Europe.
The Commission will also assess whether a country already hosts other European Union agencies to omit monopoly.
The issue will also be discussed by minister in October.
If any one gets three points from 14 or more members then it automatically wins - otherwise there is a second round for the top three candidate cities but with each country only getting one vote each.
Cities of the great majority of member States are in competition for the AEM, which is in charge of the scientific evaluation, supervision, and security controls for the drugs to uses in human and veterinary products marketed in the EU.
Should there still be no clear victor, there will be a third and final knock-out round between the two final candidates.